Prohance and nephrogenic systemic fibrosis Patient Reports February 13, 2012

Prohance Side Effects Report #6032826-5
Prohance side effect was reported by a Health Professional from UNITED STATES on Sept 09, 2008. Male patient, 59 years of age, weighting 165.3 lb, was diagnosed with nuclear magnetic resonance imaging brain, venogram renal, renal arteritis and was treated with Prohance. After drug was administered, patient experienced the following side effects: nephrogenic systemic fibrosis. Prohance dosage: unknown. During the same period patient was treated with MAGNEVIST. Patient was hospitalized and became disabled. Patient recovered.

Prohance Side Effects Report #6032933-7
Prohance side effect was reported by a Health Professional from UNITED STATES on Sept 09, 2008. Male patient, 59 years of age, weighting 165.3 lb, was diagnosed with nuclear magnetic resonance imaging brain and was treated with Prohance. After drug was administered, patient experienced the following side effects: nephrogenic systemic fibrosis. Prohance dosage: unknown. During the same period patient was treated with MAGNEVIST, OMNISCAN, ZYLOPRIM, ZANTAC. Patient was hospitalized and became disabled. Patient recovered.

Prohance Side Effects Report #5977127-6
Prohance side effect was reported by a Health Professional from UNITED STATES on Nov 25, 2008. Female patient, weighting 189.6 lb, was diagnosed with nuclear magnetic resonance imaging brain, angiogram, nuclear magnetic resonance imaging abdominal and was treated with Prohance. After drug was administered, patient experienced the following side effects: granuloma, nephrogenic systemic fibrosis. Prohance dosage: unknown. During the same period patient was treated with OMNISCAN, ALPRAZOLAM, CALCIUM, ESTROGEN NOS, FERROUS SULPHATE. Patient recovered.

Prohance Side Effects Report #6032829-0
Prohance side effect was reported by a Health Professional from UNITED STATES on Sept 09, 2008. Male patient, 71 years of age, weighting 209.4 lb, was diagnosed with nuclear magnetic resonance imaging, angiogram and was treated with Prohance. After drug was administered, patient experienced the following side effects: nephrogenic systemic fibrosis. Prohance dosage: unknown. During the same period patient was treated with OMNISCAN, OMNIPAQUE, PROZAC, DOCUSATE. Patient recovered.


Prohance Side Effects Report #6032710-7
Prohance side effect was reported by a Health Professional from UNITED STATES on Sept 09, 2008. Male patient, 48 years of age, weighting 205.0 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Prohance. After drug was administered, patient experienced the following side effects: nephrogenic systemic fibrosis. Prohance dosage: unknown. During the same period patient was treated with MAGNEVIST, RENAGEL, PHOSLO, LOMOTIL, TEMAZEPAM, INSULIN, ACCUPRIL, CATAPRES PATCH. Patient was hospitalized and became disabled. Patient recovered.

Prohance Side Effects Report #6032822-8
Prohance side effect was reported by a Health Professional from UNITED STATES on Sept 09, 2008. Male patient, 48 years of age, weighting 205.0 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Prohance. After drug was administered, patient experienced the following side effects: nephrogenic systemic fibrosis. Prohance dosage: unknown. During the same period patient was treated with MAGNEVIST, RENAGEL, PHOSLO, LOMOTIL, TEMAZEPAM, INSULIN, ACCUPRIL, CATAPRES PATCH. Patient was hospitalized and became disabled. Patient recovered.

Prohance Side Effects Report #6032735-1
Prohance side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2008. Male patient, child 11 years of age, weighting 77.16 lb, was diagnosed with nuclear magnetic resonance imaging and was treated with Prohance. After drug was administered, patient experienced the following side effects: cardiac valve disease, discomfort, fibrosis, metaplasia, mobility decreased, muscle contracture, myocardial fibrosis, nephrogenic systemic fibrosis, pain . Prohance dosage: unknown. During the same period patient was treated with MAGNEVIST, OMNISCAN. Patient was hospitalized and became disabled. Patient died on 01/17/2005.

Prohance Side Effects Report #5719271-4
Prohance side effect was reported by a Physician from GERMANY on Apr 18, 2008. Male patient, weighting 156.5 lb, was diagnosed with diagnostic procedure, multiple myeloma  and was treated with Prohance. After drug was administered, patient experienced the following side effects: nephrogenic systemic fibrosis. Prohance dosage: unknown. During the same period patient was treated with MAGNEVIST, CYTARABINE, THALIDOMIDE. Patient recovered.

Prohance Side Effects Report #6032937-4
Prohance side effect was reported by a Health Professional from UNITED STATES on Sept 09, 2008. Male patient, 71 years of age, weighting 209.4 lb, was diagnosed with angiogram, nuclear magnetic resonance imaging and was treated with Prohance. After drug was administered, patient experienced the following side effects: nephrogenic systemic fibrosis. Prohance dosage: unknown. During the same period patient was treated with OMNISCAN, CONTRAST PRODUCT, GADOLINIUM PRODUCT, OMNIPAQUE. Patient recovered.